Cytokinetics Stock Market Value

CYTK
 Stock
  

USD 50.68  0.12  0.24%   

Cytokinetics' market value is the price at which a share of Cytokinetics stock trades on a public exchange. It measures the collective expectations of Cytokinetics investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Cytokinetics and determine expected loss or profit from investing in Cytokinetics over a given investment horizon. Continue to Cytokinetics Correlation, Cytokinetics Volatility and Cytokinetics Alpha and Beta module to complement your research on Cytokinetics.
Symbol


Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.8 B
Quarterly Revenue Growth YOY
30.29
Return On Assets
-0.17
Return On Equity
-3.38
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cytokinetics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cytokinetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cytokinetics.
0.00
07/20/2022
No Change 0.00  0.0 
In 31 days
08/19/2022
0.00
If you would invest  0.00  in Cytokinetics on July 20, 2022 and sell it all today you would earn a total of 0.00 from holding Cytokinetics or generate 0.0% return on investment in Cytokinetics over 30 days. Cytokinetics is related to or competes with International Business. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializ... More

Cytokinetics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cytokinetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cytokinetics upside and downside potential and time the market with a certain degree of confidence.

Cytokinetics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cytokinetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cytokinetics' standard deviation. In reality, there are many statistical measures that can use Cytokinetics historical prices to predict the future Cytokinetics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cytokinetics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
45.6850.4255.16
Details
Intrinsic
Valuation
LowReal ValueHigh
42.6047.3452.08
Details
Naive
Forecast
LowNext ValueHigh
44.5149.2453.98
Details
11 Analysts
Consensus
LowTarget PriceHigh
40.0054.6775.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytokinetics. Your research has to be compared to or analyzed against Cytokinetics' peers to derive any actionable benefits. When done correctly, Cytokinetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cytokinetics.

Cytokinetics Backtested Returns

Cytokinetics appears to be very steady, given 3 months investment horizon. Cytokinetics secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had 0.11% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. By analyzing Cytokinetics technical indicators you can presently evaluate if the expected return of 0.5% is justified by implied risk. Please makes use of Cytokinetics' Risk Adjusted Performance of 0.1099, downside deviation of 5.53, and Mean Deviation of 3.22 to double-check if our risk estimates are consistent with your expectations.
On a scale of 0 to 100, Cytokinetics holds a performance score of 8. The firm shows a Beta (market volatility) of 1.325, which signifies a somewhat significant risk relative to the market. Let's try to break down what Cytokinetics's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cytokinetics will likely underperform. Although it is vital to follow Cytokinetics historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-one technical indicators for Cytokinetics, which you can use to evaluate the performance of the firm. Please makes use of Cytokinetics variance, value at risk, as well as the relationship between the Value At Risk and skewness to make a quick decision on whether Cytokinetics price patterns will revert.

Auto-correlation

    
  -0.2  

Insignificant reverse predictability

Cytokinetics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Cytokinetics time series from 20th of July 2022 to 4th of August 2022 and 4th of August 2022 to 19th of August 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cytokinetics price movement. The serial correlation of -0.2 indicates that over 20.0% of current Cytokinetics price fluctuation can be explain by its past prices.
Correlation Coefficient-0.2
Spearman Rank Test-0.28
Residual Average0.0
Price Variance2.82

Cytokinetics lagged returns against current returns

Autocorrelation, which is Cytokinetics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cytokinetics' stock expected returns. We can calculate the autocorrelation of Cytokinetics returns to help us make a trade decision. For example, suppose you find that Cytokinetics stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   
Share
       Timeline  

Cytokinetics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cytokinetics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cytokinetics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cytokinetics stock over time.
   Current vs Lagged Prices   
Share
       Timeline  

Cytokinetics Lagged Returns

When evaluating Cytokinetics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cytokinetics stock have on its future price. Cytokinetics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cytokinetics autocorrelation shows the relationship between Cytokinetics stock current value and its past values and can show if there is a momentum factor associated with investing in Cytokinetics.
   Regressed Prices   
Share
       Timeline  

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cytokinetics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

Pair Trading with Cytokinetics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytokinetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cytokinetics

0.64CVMCel-Sci Corp Fiscal Year End 28th of December 2022 PairCorr
0.8BCRXBiocryst Pharma Normal TradingPairCorr

Moving against Cytokinetics

0.7KZIAKazia Therapeutics Fiscal Year End 6th of October 2022 PairCorr
The ability to find closely correlated positions to Cytokinetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytokinetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytokinetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytokinetics to buy it.
The correlation of Cytokinetics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytokinetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytokinetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytokinetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Cytokinetics Correlation, Cytokinetics Volatility and Cytokinetics Alpha and Beta module to complement your research on Cytokinetics. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Cytokinetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cytokinetics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cytokinetics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...